FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139717439> ?p ?o ?g. }

• W2139717439 endingPage "2365" @default.
• W2139717439 startingPage "2358" @default.
• W2139717439 abstract "Abstract We conducted a multi-institutional randomized study to determine whether high-dose daunorubicin would be as effective as standard-dose idarubicin in remission-induction therapy for newly diagnosed adult patients younger than 65 years of age with acute myeloid leukemia. Of 1064 patients registered, 1057 were evaluable. They were randomly assigned to receive either daunorubicin (50 mg/m2 daily for 5 days) or idarubicin (12 mg/m2 daily for 3 days) in combination with 100 mg/m2 of cytarabine by continuous infusion daily for 7 days as induction therapy. Complete remission was achieved in 407 (77.5%) of 525 patients in the daunorubicin group and 416 (78.2%) of 532 in the idarubicin group (P = .79). Patients achieving complete remission received intensive postremission therapy that consisted of either 3 courses of high-dose cytarabine or 4 courses of standard-dose therapy. Overall survival rates at 5 years were 48% for the daunorubicin group and 48% for the idarubicin group (P = .54), and relapse-free survival rates at 5 years were 41% and 41% (P = .97), respectively. Thus, high-dose daunorubicin and standard-dose idarubicin were equally effective for the treatment of adult acute myeloid leukemia, achieving a high rate of complete remission and good long-term efficacy. This study is registered at http://www.umin.ac.jp/ctrj/ as C000000157." @default.
• W2139717439 created "2016-06-24" @default.
• W2139717439 creator A5000733045 @default.
• W2139717439 creator A5001496361 @default.
• W2139717439 creator A5002642944 @default.
• W2139717439 creator A5011880079 @default.
• W2139717439 creator A5013146671 @default.
• W2139717439 creator A5017936080 @default.
• W2139717439 creator A5017994748 @default.
• W2139717439 creator A5018101881 @default.
• W2139717439 creator A5028457340 @default.
• W2139717439 creator A5030723283 @default.
• W2139717439 creator A5037291528 @default.
• W2139717439 creator A5037362999 @default.
• W2139717439 creator A5039801586 @default.
• W2139717439 creator A5045270299 @default.
• W2139717439 creator A5060267855 @default.
• W2139717439 creator A5060593609 @default.
• W2139717439 creator A5063488239 @default.
• W2139717439 creator A5066174292 @default.
• W2139717439 creator A5066595600 @default.
• W2139717439 creator A5068249765 @default.
• W2139717439 creator A5070702322 @default.
• W2139717439 creator A5074811645 @default.
• W2139717439 creator A5083055988 @default.
• W2139717439 creator A5084655190 @default.
• W2139717439 date "2011-02-24" @default.
• W2139717439 modified "2023-10-06" @default.
• W2139717439 title "Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study" @default.
• W2139717439 cites W1492445977 @default.
• W2139717439 cites W1534965621 @default.
• W2139717439 cites W1586763410 @default.
• W2139717439 cites W1756796371 @default.
• W2139717439 cites W1808968650 @default.
• W2139717439 cites W1861929829 @default.
• W2139717439 cites W1969545468 @default.
• W2139717439 cites W1971280577 @default.
• W2139717439 cites W2001028523 @default.
• W2139717439 cites W2008559715 @default.
• W2139717439 cites W2019793347 @default.
• W2139717439 cites W2035661456 @default.
• W2139717439 cites W2039412651 @default.
• W2139717439 cites W2044942890 @default.
• W2139717439 cites W2061263203 @default.
• W2139717439 cites W2069448515 @default.
• W2139717439 cites W2079025304 @default.
• W2139717439 cites W2081532971 @default.
• W2139717439 cites W2090984104 @default.
• W2139717439 cites W2138571761 @default.
• W2139717439 cites W2159507916 @default.
• W2139717439 cites W2187668060 @default.
• W2139717439 cites W2315152253 @default.
• W2139717439 cites W2317674375 @default.
• W2139717439 cites W2318674152 @default.
• W2139717439 cites W2497311781 @default.
• W2139717439 cites W4237785786 @default.
• W2139717439 cites W4239564692 @default.
• W2139717439 cites W4251088709 @default.
• W2139717439 cites W4253679382 @default.
• W2139717439 cites W4293241248 @default.
• W2139717439 cites W4312790597 @default.
• W2139717439 cites W4376595466 @default.
• W2139717439 cites W4385970358 @default.
• W2139717439 cites W70444494 @default.
• W2139717439 doi "https://doi.org/10.1182/blood-2010-03-273243" @default.
• W2139717439 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20693429" @default.
• W2139717439 hasPublicationYear "2011" @default.
• W2139717439 type Work @default.
• W2139717439 sameAs 2139717439 @default.
• W2139717439 citedByCount "202" @default.
• W2139717439 countsByYear W21397174392012 @default.
• W2139717439 countsByYear W21397174392013 @default.
• W2139717439 countsByYear W21397174392014 @default.
• W2139717439 countsByYear W21397174392015 @default.
• W2139717439 countsByYear W21397174392016 @default.
• W2139717439 countsByYear W21397174392017 @default.
• W2139717439 countsByYear W21397174392018 @default.
• W2139717439 countsByYear W21397174392019 @default.
• W2139717439 countsByYear W21397174392020 @default.
• W2139717439 countsByYear W21397174392021 @default.
• W2139717439 countsByYear W21397174392022 @default.
• W2139717439 countsByYear W21397174392023 @default.
• W2139717439 crossrefType "journal-article" @default.
• W2139717439 hasAuthorship W2139717439A5000733045 @default.
• W2139717439 hasAuthorship W2139717439A5001496361 @default.
• W2139717439 hasAuthorship W2139717439A5002642944 @default.
• W2139717439 hasAuthorship W2139717439A5011880079 @default.
• W2139717439 hasAuthorship W2139717439A5013146671 @default.
• W2139717439 hasAuthorship W2139717439A5017936080 @default.
• W2139717439 hasAuthorship W2139717439A5017994748 @default.
• W2139717439 hasAuthorship W2139717439A5018101881 @default.
• W2139717439 hasAuthorship W2139717439A5028457340 @default.
• W2139717439 hasAuthorship W2139717439A5030723283 @default.
• W2139717439 hasAuthorship W2139717439A5037291528 @default.
• W2139717439 hasAuthorship W2139717439A5037362999 @default.
• W2139717439 hasAuthorship W2139717439A5039801586 @default.
• W2139717439 hasAuthorship W2139717439A5045270299 @default.
• W2139717439 hasAuthorship W2139717439A5060267855 @default.

• next